The experimental results suggested that downregulated miR-218 and upregulated MITF improved cardiac function, alleviated pathological damage of cardiac tissues, reduced cardiac fibrosis, promoted angiogenesis, and reduced oxidative stress and inflammatory injury in MI rat models. The gene discussed is MITF; the disease is myocardial infarction.